These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6101508)

  • 1. Adrenergic modulation of extrarenal potassium disposal.
    Rosa RM; Silva P; Young JB; Landsberg L; Brown RS; Rowe JW; Epstein FH
    N Engl J Med; 1980 Feb; 302(8):431-4. PubMed ID: 6101508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
    Yang WC; Huang TP; Ho LT; Chung HM; Chan YL; Batlle DC
    Miner Electrolyte Metab; 1986; 12(3):186-93. PubMed ID: 2873504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia.
    Martinez Vea A; Montoliu J; Andreu L; Torras A; Gaya J; López-Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 19():756-60. PubMed ID: 6136035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of extrarenal potassium disposal by alpha-adrenergic stimulation.
    Williams ME; Rosa RM; Silva P; Brown RS; Epstein FH
    N Engl J Med; 1984 Jul; 311(3):145-9. PubMed ID: 6330550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine modulation of rapid potassium shifts during exercise.
    Williams ME; Gervino EV; Rosa RM; Landsberg L; Young JB; Silva P; Epstein FH
    N Engl J Med; 1985 Mar; 312(13):823-7. PubMed ID: 2858053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and beta receptor modulation of K homeostasis in nephrectomized dogs with hyperkalemia.
    Hiatt N; Chapman LW; Davidson MB; Sheinkopf JA; Mack H; Low J; Sawicki G
    Horm Metab Res; 1982 Jun; 14(6):299-302. PubMed ID: 6288538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
    Arrizabalaga P; Montoliu J; Martinez Vea A; Andreu L; López Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 20():572-6. PubMed ID: 6318223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic modulation of potassium metabolism during exercise in normal and diabetic humans.
    Castellino P; Simonson DC; DeFronzo RA
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E68-76. PubMed ID: 3544863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease.
    Allon M; Shanklin N
    Kidney Int; 1991 Dec; 40(6):1103-9. PubMed ID: 1662320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adrenergic regulation of potassium homeostasis].
    Martín C; González Buitrago JM; Laso FJ
    Med Clin (Barc); 1991 Mar; 96(11):424-7. PubMed ID: 1675314
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta adrenergic control of extrarenal potassium disposal. A beta-2 mediated phenomenon.
    Bia MJ; Lu D; Tyler K; De Fronzo RA
    Nephron; 1986; 43(2):117-22. PubMed ID: 2872603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine and potassium homeostasis.
    DeFronzo RA; Bia M; Birkhead G
    Kidney Int; 1981 Jul; 20(1):83-91. PubMed ID: 7300118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
    Allon M; Dansby L; Shanklin N
    Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
    Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired extrarenal disposal of an acute oral potassium load in patients with endstage renal disease on chronic hemodialysis.
    Fernandez J; Oster JR; Perez GO
    Miner Electrolyte Metab; 1986; 12(2):125-9. PubMed ID: 3960016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
    Beylot M; Sautot G; Dechaud H; Cohen R; Riou JP; Serusclat P; Mornex R
    Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.
    Kraenzlin ME; Keller U; Keller A; Thélin A; Arnaud MJ; Stauffacher W
    J Clin Invest; 1989 Aug; 84(2):388-93. PubMed ID: 2569473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alpha-adrenergic hormones in potassium homeostasis in the rat.
    Williams ME; Spokes K; Silva P
    J Lab Clin Med; 1987 Aug; 110(2):245-9. PubMed ID: 3298508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.
    Allon M; Takeshian A; Shanklin N
    Kidney Int; 1993 Jan; 43(1):212-7. PubMed ID: 8433561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.